Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05323045 |
| Title | A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Byondis B.V. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NLD | ITA | GBR | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Institut Jules Bordet | Brussels | Belgium | Details | |||
| Istituto Europeo di Oncologia | Milan | 1070 | Italy | Details | ||
| Radboud | Nijmegen | 6500HB | Netherlands | Details | ||
| Royal Marsden | London | SM2 5PT | United Kingdom | Details |